Becton Dickinson (BDX) Deferred Taxes (2009 - 2026)
Becton Dickinson's (BDX) quarterly Deferred Taxes came in at -$73.0 million in Q1 2026, up 32.41% year-on-year from -$55.1 million in Q1 2025, and down 351.72% on a QoQ basis from $29.0 million in Q4 2025.
Becton Dickinson (BDX) Deferred Taxes (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Deferred Taxes data on file, last reported at -$73.0 million in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 32.41% year-over-year to -$73.0 million in Q1 2026; TTM through Mar 2026 was -$259.0 million, a 19.31% increase from a year earlier, with the FY2025 full-year figure at -$474.0 million, down 124.64% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$73.0 million, down from $29.0 million in the prior quarter.
- Over the last five years, Deferred Taxes for BDX reached as high as $88.0 million in Q3 2024 and fell as low as -$219.0 million in Q3 2025.
- Historically, Deferred Taxes has averaged -$82.5 million across 5 years, with a median of -$91.0 million in 2023.
- Across the five-year window, Deferred Taxes sank 1393.75% in 2023 and soared 144.44% in 2024, its largest moves.
- Year by year, Deferred Taxes stood at -$118.0 million in 2022, then climbed by 22.88% to -$91.0 million in 2023, then tumbled by 65.93% to -$151.0 million in 2024, then surged by 119.21% to $29.0 million in 2025, then tumbled by 351.72% to -$73.0 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$73.0 million in Q1 2026, $29.0 million in Q4 2025, and -$219.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -73.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 37.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 43.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -41.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.64 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 29.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.00 Mn |
| Dec 31, 2025 | 29.00 Mn |
| Sep 30, 2025 | -219.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | -108.00 Mn |
| Dec 31, 2024 | -151.00 Mn |
| Sep 30, 2024 | 88.00 Mn |
| Jun 30, 2024 | -150.00 Mn |
| Mar 31, 2024 | -58.00 Mn |
| Dec 31, 2023 | -91.00 Mn |
| Sep 30, 2023 | -198.00 Mn |
| Jun 30, 2023 | -99.00 Mn |
| Mar 31, 2023 | -207.00 Mn |
| Dec 31, 2022 | -118.00 Mn |
| Sep 30, 2022 | -21.00 Mn |
| Jun 30, 2022 | -46.00 Mn |
| Mar 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | -69.00 Mn |
| Sep 30, 2021 | -206.00 Mn |
| Jun 30, 2021 | 25.00 Mn |